No new guid­ance, but here's some ad­vice: FDA draws a line in the sand for Covid-19 vac­cine de­vel­op­ers

Less than a day af­ter re­ports emerged that the White House cit­ed in­dus­try op­po­si­tion in a move to block stricter Covid-19 vac­cine guide­lines, the FDA is spelling out ex­act­ly what reg­u­la­tors have been com­mu­ni­cat­ing to de­vel­op­ers look­ing for an emer­gency use au­tho­riza­tion.

In do­ing so, the reg­u­la­tors are of­fi­cial­ly draw­ing a line in the sand amid an in­creas­ing­ly chaot­ic cam­paign to bring a vac­cine to mar­ket at record speed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER